BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 24916890)

  • 1. A prognostic classifier consisting of 17 circulating cytokines is a novel predictor of overall survival for metastatic colorectal cancer patients.
    Chen ZY; He WZ; Peng LX; Jia WH; Guo RP; Xia LP; Qian CN
    Int J Cancer; 2015 Feb; 136(3):584-92. PubMed ID: 24916890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohorts.
    Chen ZY; Wei W; Guo ZX; Peng LX; Shi M; Li SH; Xiao CZ; Zhong C; Qian CN; Guo RP
    Br J Cancer; 2014 Feb; 110(3):733-40. PubMed ID: 24495874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated serum concentration of monocyte chemotactic protein 4 (MCP-4) as a novel non-invasive prognostic and predictive biomarker for detection of metastasis in colorectal cancer.
    Okugawa Y; Toiyama Y; Mohri Y; Tanaka K; Kawamura M; Hiro J; Araki T; Inoue Y; Miki C; Kusunoki M
    J Surg Oncol; 2016 Sep; 114(4):483-9. PubMed ID: 27349356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Joint prognostic effect of obesity and chronic systemic inflammation in patients with metastatic colorectal cancer.
    Shah MS; Fogelman DR; Raghav KP; Heymach JV; Tran HT; Jiang ZQ; Kopetz S; Daniel CR
    Cancer; 2015 Sep; 121(17):2968-75. PubMed ID: 25975416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
    Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
    Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer.
    Chen ZY; Raghav K; Lieu CH; Jiang ZQ; Eng C; Vauthey JN; Chang GJ; Qiao W; Morris J; Hong D; Hoff P; Tran H; Menter DG; Heymach J; Overman M; Kopetz S
    Br J Cancer; 2015 Mar; 112(6):1088-97. PubMed ID: 25688736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophage inflammatory protein-3 alpha (MIP-3a) is a novel serum prognostic marker in patients with colorectal cancer.
    Iwata T; Tanaka K; Inoue Y; Toiyama Y; Hiro J; Fujikawa H; Okugawa Y; Uchida K; Mohri Y; Kusunoki M
    J Surg Oncol; 2013 Feb; 107(2):160-6. PubMed ID: 22926691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profiles of circulating inflammatory cytokines in colorectal cancer (CRC), high cancer risk conditions, and health are distinct. Possible implications for CRC screening and surveillance.
    Krzystek-Korpacka M; Diakowska D; Kapturkiewicz B; Bębenek M; Gamian A
    Cancer Lett; 2013 Aug; 337(1):107-14. PubMed ID: 23726839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-free DNA in healthy individuals, noncancerous disease and strong prognostic value in colorectal cancer.
    Spindler KL; Appelt AL; Pallisgaard N; Andersen RF; Brandslund I; Jakobsen A
    Int J Cancer; 2014 Dec; 135(12):2984-91. PubMed ID: 24798213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
    Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
    J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating midkine in malignant and non-malignant colorectal diseases.
    Krzystek-Korpacka M; Diakowska D; Neubauer K; Gamian A
    Cytokine; 2013 Oct; 64(1):158-64. PubMed ID: 23899719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis.
    Rutkowski P; Kaminska J; Kowalska M; Ruka W; Steffen J
    Int J Cancer; 2002 Aug; 100(4):463-71. PubMed ID: 12115531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCL5, a promoter of cell proliferation, migration and invasion, is a novel serum prognostic marker in patients with colorectal cancer.
    Kawamura M; Toiyama Y; Tanaka K; Saigusa S; Okugawa Y; Hiro J; Uchida K; Mohri Y; Inoue Y; Kusunoki M
    Eur J Cancer; 2012 Sep; 48(14):2244-51. PubMed ID: 22197219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genome-wide DNA methylation analysis reveals a prognostic classifier for non-metastatic colorectal cancer (ProMCol classifier).
    Gündert M; Edelmann D; Benner A; Jansen L; Jia M; Walter V; Knebel P; Herpel E; Chang-Claude J; Hoffmeister M; Brenner H; Burwinkel B
    Gut; 2019 Jan; 68(1):101-110. PubMed ID: 29101262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on the prognostic factors of colorectal cancer and on suggested model for prediction].
    Liu W; Nie SF; Chen JG; Huang T; He JJ; Liu C
    Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Jul; 28(7):700-3. PubMed ID: 18069564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cediranib plus FOLFOX/CAPOX versus placebo plus FOLFOX/CAPOX in patients with previously untreated metastatic colorectal cancer: a randomized, double-blind, phase III study (HORIZON II).
    Hoff PM; Hochhaus A; Pestalozzi BC; Tebbutt NC; Li J; Kim TW; Koynov KD; Kurteva G; Pintér T; Cheng Y; van Eyll B; Pike L; Fielding A; Robertson JD; Saunders MP
    J Clin Oncol; 2012 Oct; 30(29):3596-603. PubMed ID: 22965965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma-glutamyl transpeptidase level is a novel adverse prognostic indicator in human metastatic colorectal cancer.
    He WZ; Guo GF; Yin CX; Jiang C; Wang F; Qiu HJ; Chen XX; Rong RM; Zhang B; Xia LP
    Colorectal Dis; 2013 Aug; 15(8):e443-52. PubMed ID: 23621885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PKA RIα/A-kinase anchoring proteins 10 signaling pathway and the prognosis of colorectal cancer.
    Wang M; Li Y; Wang R; Wang Z; Chen K; Zhou B; Zhou Z; Sun X
    J Gastroenterol Hepatol; 2015 Mar; 30(3):496-503. PubMed ID: 25213315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLIC4, ERp29, and Smac/DIABLO derived from metastatic cancer stem-like cells stratify prognostic risks of colorectal cancer.
    Deng YJ; Tang N; Liu C; Zhang JY; An SL; Peng YL; Ma LL; Li GQ; Jiang Q; Hu CT; Wang YN; Liang YZ; Bian XW; Fang WG; Ding YQ
    Clin Cancer Res; 2014 Jul; 20(14):3809-17. PubMed ID: 24916695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling-derived immunohistochemistry signature with high prognostic value in colorectal carcinoma.
    Chang W; Gao X; Han Y; Du Y; Liu Q; Wang L; Tan X; Zhang Q; Liu Y; Zhu Y; Yu Y; Fan X; Zhang H; Zhou W; Wang J; Fu C; Cao G
    Gut; 2014 Sep; 63(9):1457-67. PubMed ID: 24173294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.